Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Author: Benzinga Insights | August 05, 2025 08:08am

Gainers

  • Staar Surgical (NASDAQ:STAA) stock increased by 44.8% to $26.77 during Tuesday's pre-market session. The market value of their outstanding shares is at $915.7 million.
  • Adaptimmune Therapeutics (NASDAQ:ADAP) stock rose 32.15% to $0.1. The market value of their outstanding shares is at $21.0 million.
  • Shattuck Labs (NASDAQ:STTK) stock rose 32.13% to $0.98. The company's market cap stands at $35.5 million.
  • Castle Biosciences (NASDAQ:CSTL) shares moved upwards by 25.97% to $19.3. The market value of their outstanding shares is at $441.9 million. The company's, Q2 earnings came out yesterday.
  • Sensei Biotherapeutics (NASDAQ:SNSE) stock increased by 18.38% to $10.24. The company's market cap stands at $10.9 million. As per the news, the Q2 earnings report came out today.
  • Axogen (NASDAQ:AXGN) shares moved upwards by 15.61% to $14.51. The company's market cap stands at $571.5 million. The company's, Q2 earnings came out today.

Losers

  • Agilon Health (NYSE:AGL) stock decreased by 30.6% to $1.26 during Tuesday's pre-market session. The market value of their outstanding shares is at $751.3 million. As per the news, the Q2 earnings report came out today.
  • Inspire Medical Systems (NYSE:INSP) stock declined by 29.13% to $92.1. The market value of their outstanding shares is at $3.8 billion. As per the news, the Q2 earnings report came out yesterday.
  • Vertex Pharmaceuticals (NASDAQ:VRTX) shares declined by 13.19% to $410.0. The company's market cap stands at $121.2 billion. As per the press release, Q2 earnings came out yesterday.
  • Hims & Hers Health (NYSE:HIMS) shares declined by 11.23% to $56.24. The company's market cap stands at $14.1 billion. The company's, Q2 earnings came out yesterday.
  • Longeveron (NASDAQ:LGVN) stock decreased by 11.12% to $1.52. The company's market cap stands at $25.6 million.
  • Leap Therapeutics (NASDAQ:LPTX) stock declined by 10.29% to $0.32. The market value of their outstanding shares is at $14.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ADAP AGL AXGN CSTL HIMS INSP LGVN LPTX SNSE STAA STTK VRTX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist